These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 9375705)

  • 1. Hyperuricemia as a clue for central diabetes insipidus (lack of V1 effect) in the differential diagnosis of polydipsia.
    Decaux G; Prospert F; Namias B; Soupart A
    Am J Med; 1997 Nov; 103(5):376-82. PubMed ID: 9375705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence in hyponatremia related to inappropriate secretion of ADH that V1 receptor stimulation contributes to the increase in renal uric acid clearance.
    Decaux G; Namias B; Gulbis B; Soupart A
    J Am Soc Nephrol; 1996 May; 7(5):805-10. PubMed ID: 8738818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A COMBINED OUTPATIENT AND INPATIENT OVERNIGHT WATER DEPRIVATION TEST IS EFFECTIVE AND SAFE IN DIAGNOSING PATIENTS WITH POLYURIA-POLYDIPSIA SYNDROME.
    Pedrosa W; Drummond JB; Soares BS; Ribeiro-Oliveira A
    Endocr Pract; 2018 Nov; 24(11):963-972. PubMed ID: 30106630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2.
    Joo KW; Jeon US; Kim GH; Park J; Oh YK; Kim YS; Ahn C; Kim S; Kim SY; Lee JS; Han JS
    Nephrol Dial Transplant; 2004 Oct; 19(10):2480-6. PubMed ID: 15280526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
    N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid differential diagnosis of diabetes insipidus in a 7-month-old infant: The copeptin approach.
    Vergier J; Fromonot J; Alvares De Azevedo Macedo A; Godefroy A; Marquant E; Guieu R; Tsimaratos M; Reynaud R
    Arch Pediatr; 2018 Jan; 25(1):45-47. PubMed ID: 29241593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans.
    Bankir L; Fernandes S; Bardoux P; Bouby N; Bichet DG
    J Am Soc Nephrol; 2005 Jul; 16(7):1920-8. PubMed ID: 15888562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of COX-1, COX-2, and mPGES in rats with nephrogenic and central diabetes insipidus.
    Kotnik P; Nielsen J; Kwon TH; Krzisnik C; Frøkiaer J; Nielsen S
    Am J Physiol Renal Physiol; 2005 May; 288(5):F1053-68. PubMed ID: 15644490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of diagnostic methods to differentiate diabetes insipidus from primary polyuria: a review of 21 patients.
    Milles JJ; Spruce B; Baylis PH
    Acta Endocrinol (Copenh); 1983 Dec; 104(4):410-6. PubMed ID: 6659843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
    Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
    Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low serum urea level in dehydrated patients with central diabetes insipidus.
    Comtois R; Bertrand S; Beauregard H; Vinay P
    CMAJ; 1988 Nov; 139(10):965-9. PubMed ID: 3179869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential diagnosis of polyuric/polydipsic syndromes with the aid of urinary vasopressin measurement in adults.
    Diederich S; Eckmanns T; Exner P; Al-Saadi N; Bähr V; Oelkers W
    Clin Endocrinol (Oxf); 2001 May; 54(5):665-71. PubMed ID: 11380498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolytic responses to 1-desamino-8-D-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Knoers N; Brommer EJ; Willems H; van Oost BA; Monnens LA
    Nephron; 1990; 54(4):322-6. PubMed ID: 2109264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum Uric Acid Level and Its Influencing Factors in Patients with Diabetes Insipidus].
    Wang SH; Zhu HJ; Duan L; Ping F; Wang X; Chi Y; Yuan T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Feb; 45(1):44-49. PubMed ID: 36861154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetes insipidus: etiology, diagnosis, and therapy].
    Laczi F
    Orv Hetil; 2002 Nov; 143(46):2579-85. PubMed ID: 12520852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient central diabetes insipidus in the setting of underlying chronic nephrogenic diabetes insipidus associated with lithium use.
    Posner L; Mokrzycki MH
    Am J Nephrol; 1996; 16(4):339-43. PubMed ID: 8739289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gestational diabetes insipidus: Diagnosis and management.
    Ananthakrishnan S
    Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101384. PubMed ID: 32205050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of the uricosuric effect of probenecid after triglycylvasopressine administration in a gouty patient.
    Decaux G; Soupart A; Musch W; Hannotier P; Prospert F
    Clin Nephrol; 1998 Oct; 50(4):262-5. PubMed ID: 9799074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models for diabetes insipidus.
    Mahía J; Bernal A
    Handb Clin Neurol; 2021; 181():275-288. PubMed ID: 34238463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.